Together, as a community, we can emphasize the importance of diagnostic testing as a critical step to reach the goal of an AIDS-free generation by 2030. Meeting UNAIDS elimination goals1 is impossible without testing.
ARTICLE
To address this challenge, many of the world's top relief and aid organizations have joined together with an ambitious goal: to end stop many diseases.
In 2014, Roche announced, the Global Access Program. In 2019, the Program was expanded to include Tuberculosis (TB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV).
Roche continues to partner with national governments, local healthcare facilities, communities and international agencies, including UNAIDS, CHAI, Unitaid, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund, and Centres for Disease Control (CDC), to establish The Global Access Program that would go beyond providing diagnostic tests.
Together, as a community, we can emphasize the importance of diagnostic testing as a critical step to reach the goal of an AIDS-free generation by 2030. Meeting UNAIDS elimination goals1 is impossible without testing.
The Roche Global Access Program has sustainable HIV diagnostic solutions to countries battling the HIV/AIDS epidemic.
Fighting HIV/AIDS: How Does it Work and What Can it Achieve?
Early identification of HIV infection in newborns is essential to initiate treatment promptly.
References